ALSP Orchid Acquisition Corporation I

ALSP Orchid Acquisition Corporation I

ALORW
ALSP Orchid Acquisition Corporation IUS flagNASDAQ Global Market
0.00
USD
+0.00
- -
78.60MMarket Cap
ALSP Orchid Acquisition Corporation I
ALORW
(NASDAQ Global Market)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
ALSP Orchid Acquisition Corporation I is a special purpose acquisition company (SPAC) formed in 2021 and headquartered in Seattle, Washington. The company does not have significant operations of its own but is established to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations, primarily targeting life science companies in North America and Singapore. It is formed by Accelerator Life Science Partners and leverages an experienced management team with expertise in healthcare, biotechnology, and life sciences sectors. ALSP Orchid's business model focuses on identifying and acquiring companies developing assets and next-generation platform technologies with broad applicability within the life sciences industry. Recently, ALSP Orchid announced that it would redeem its public shares and will not consummate an initial business combination within the required timeframe, leading to the cessation of its operations except for winding up its business, signaling a major operational conclusion within the past year. The company is affiliated with ALSP Orchid Sponsor LLC and has positioned itself as a blank check vehicle with a strategic emphasis on healthcare and life sciences acquisitions, although it has yet to complete an acquisition or generate revenue. Its primary products and services revolve around facilitating capital market transactions and investment opportunities in life sciences through merger and acquisition activities rather than direct product manufacturing or service provision.